Ganga Pharmaceuticals Ltd Balance Sheet: Consolidated Financial Analysis & Historical Data (15 Years)

Annual Results

Results Snapshot

Figures in Cr

Standalone - Balance Sheet Results

Mar'26

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Balance Sheet Analysis Highlights

Borrowings

YoY Growth in year ended Mar 2026 is -23.24% vs 4.41% in Mar 2025

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

Fixed Assets

YoY Growth in year ended Mar 2026 is -1.52% vs 8.20% in Mar 2025

Investments

YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025

Current Assets

YoY Growth in year ended Mar 2026 is 10.04% vs 19.48% in Mar 2025

Compare Balance Sheet Results of Ganga Pharma.

Select Peers

Figures in Cr

Standalone - Balance Sheet Results

Change(INR)

Change(%)

No of Months

EQUITY AND LIABILITIES

Share Capital

5.91

3.05

2.86

93.77%

Share Warrants & Outstandings

Total Reserve

2.40

0.84

1.56

185.71%

Shareholder's Funds

8.31

3.90

4.41

113.08%

Minority Interest

0.00

0.00%

Long-Term Borrowings

0.10

0.00

0.10

0.00%

Secured Loans

0.00

0.00%

Unsecured Loans

0.10

0.00

0.10

0.00%

Deferred Tax Assets / Liabilities

0.00

0.00%

Other Long Term Liabilities

0.00

0.00%

Long Term Trade Payables

0.00

0.00%

Long Term Provisions

0.00

0.00%

Total Non-Current Liabilities

0.10

0.00

0.10

0.00%

Current Liabilities

Trade Payables

0.12

0.01

0.11

1,100.00%

Other Current Liabilities

0.13

0.36

-0.23

-63.89%

Short Term Borrowings

0.99

0.00

0.99

0.00%

Short Term Provisions

0.00

0.09

-0.09

-100.00%

Total Current Liabilities

1.24

0.46

0.78

169.57%

Total Liabilities

9.65

4.36

5.29

121.33%

ASSETS

Non-Current Assets

0.00

0.00%

Gross Block

1.50

0.01

1.49

14,900.00%

Less: Accumulated Depreciation

0.86

0.00

0.86

0.00%

Less : Impairment of Assets

0.00

0.00%

Net Block

0.65

0.01

0.64

6,400.00%

Lease Adjustment

0.00

0.00%

Capital Work in Progress

0.00

0.00%

Intangible assets under development

0.00

0.00%

Pre-operative Expenses pending

0.00

0.00%

Assets in transit

0.00

0.00%

Non Current Investments

0.00

0.00%

Long Term Loans & Advances

0.00

1.73

-1.73

-100.00%

Other Non Current Assets

1.44

0.00

1.44

0.00%

Total Non-Current Assets

2.08

1.73

0.35

20.23%

Current Assets Loans & Advances

Current Investments

0.00

0.00%

Inventories

1.17

0.28

0.89

317.86%

Sundry Debtors

0.94

2.21

-1.27

-57.47%

Cash and Bank

0.06

0.05

0.01

20.00%

Other Current Assets

2.48

0.00

2.48

0.00%

Short Term Loans and Advances

2.93

0.08

2.85

3,562.50%

Total Current Assets

7.56

2.62

4.94

188.55%

Net Current Assets (Including Current Investments)

6.33

2.16

4.17

193.06%

Total Current Assets Excluding Current Investments

7.56

2.62

4.94

188.55%

Miscellaneous Expenses not written off

0.00

0.00%

Total Assets

9.65

4.36

5.29

121.33%

Contingent Liabilities

0.00

0.00%

Total Debt

1.09

0.00

1.09

0.00%

Book Value per share (adjusted)

14.06

12.76

1.30

10.19%

Annual - Borrowings

Borrowings 1.09 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is -23.24% vs 4.41% in Mar 2025

Annual - Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets

Fixed Assets 0.65 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is -1.52% vs 8.20% in Mar 2025

Annual - Investments

Investments 0.00 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025

Annual - Current Assets

Current Assets 7.56 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 10.04% vs 19.48% in Mar 2025